Spontaneous Bacterial Empyema: Symptoms, Causes, Treatment

What Is Spontaneous Bacterial Empyema?

Spontaneous bacterial empyema, commonly abbreviated as SBE or SBEM, is an infection of a preexisting hepatic hydrothorax without pneumonia or another nearby source of infection. Some medical literature also calls it spontaneous bacterial pleuritis.

A hepatic hydrothorax is a buildup of fluid in the pleural spacethe narrow area between the lung and chest wallin someone with cirrhosis and portal hypertension. It is diagnosed after heart, lung, kidney, and primary pleural diseases have been excluded as likely causes.

The fluid is usually located on the right side of the chest because small defects in the diaphragm are more common there. Abdominal fluid can pass through these openings and enter the chest. A hydrothorax can still develop when little or no ascites is visible because the chest’s negative pressure may draw fluid upward as quickly as it forms.

SBE Is Not the Same as Ordinary Empyema

Conventional empyema frequently develops when pneumonia spreads into the pleural space. It may create thick pus, fibrous pockets, and a trapped lung. Spontaneous bacterial empyema develops in liver-related pleural fluid without an underlying pneumonia.

The distinction matters. Routine chest-tube drainage is standard for many complicated parapneumonic infections, but prolonged drainage of hepatic hydrothorax can cause severe protein loss, electrolyte disturbances, kidney injury, bleeding, and continuous high-volume fluid output. Treatment therefore has to balance infection control against the special risks created by decompensated liver disease.

Spontaneous Bacterial Empyema Symptoms

The presentation varies. Some patients have obvious respiratory distress, while others show only subtle changes such as fatigue, reduced appetite, or worsening confusion. Fever may be absent because advanced cirrhosis can weaken the body’s inflammatory response.

Possible symptoms and clinical signs include:

• New or worsening shortness of breath
• Fever, chills, or an unusually low body temperature
• Sharp chest pain that becomes worse with breathing
• Cough without a clear pneumonia diagnosis
• Rapid breathing or a fast heart rate
• Low oxygen levels
• Fatigue, weakness, or loss of appetite
• Confusion, sleepiness, or worsening hepatic encephalopathy
• Low blood pressure, reduced urination, or declining kidney function
• Abdominal swelling, leg swelling, or other signs of decompensated cirrhosis

A patient does not need to have every symptom. In practice, an unexplained decline in a person with cirrhosis and pleural fluid should raise suspicion. The infection may occasionally be discovered while clinicians are investigating kidney injury or altered mental status rather than a dramatic lung complaint.

What Causes Spontaneous Bacterial Empyema?

SBE begins when bacteria enter a hepatic hydrothorax. Two mechanisms probably account for many cases.

Bacteria Traveling Through the Bloodstream

Cirrhosis can impair immune defenses and make the intestinal barrier more permeable. Bacteria or bacterial products may move from the intestines to lymph nodes and then into the bloodstream. Once circulating bacteria reach low-protein pleural fluid with limited immune activity, they can establish an infection.

Movement of Infected Abdominal Fluid

If spontaneous bacterial peritonitis infects ascitic fluid, contaminated fluid may travel through microscopic diaphragmatic defects into the pleural space. However, SBE can occur without simultaneous spontaneous bacterial peritonitis and even without clinically obvious ascites. A normal abdominal fluid result therefore does not automatically give the pleural space a clean bill of health.

Common Bacteria

Reported organisms include Escherichia coli, Klebsiella pneumoniae, streptococci, enterococci, and other gram-negative bacteria. Hospital-acquired cases may involve resistant organisms, making recent hospitalization, antibiotic exposure, and local resistance patterns important when physicians select initial therapy.

Who Is Most at Risk?

Spontaneous bacterial empyema primarily affects people with advanced cirrhosis and hepatic hydrothorax. Research suggests that it develops in roughly 10% to 16% of patients with hepatic hydrothorax, although estimates differ by study population and diagnostic practices.

Factors associated with greater risk include:

• Severe or decompensated cirrhosis
• A high Child-Pugh or MELD score
• Low blood albumin
• Low protein or complement levels in pleural fluid
• Kidney dysfunction
• Previous spontaneous bacterial peritonitis
• Active spontaneous bacterial peritonitis or bloodstream infection
• Recent hospitalization or exposure to antibiotics
• Recurrent hepatic hydrothorax requiring thoracentesis

SBE is a marker of serious liver decompensation. Even when antibiotics control the immediate infection, the underlying portal hypertension and impaired liver function remain major medical concerns.

How Doctors Diagnose Spontaneous Bacterial Empyema

Symptoms and chest imaging can suggest the diagnosis, but pleural fluid analysis is essential. A clinician may begin with a chest X-ray or ultrasound to confirm the effusion. Computed tomography can help identify pneumonia, loculations, pleural thickening, or another source of infection.

Diagnostic Thoracentesis

During thoracentesis, a clinician guides a needle or small catheter between the ribs and withdraws pleural fluid. Ultrasound guidance improves accuracy and helps reduce complications. The sample may be tested for:

• White blood cells and polymorphonuclear neutrophils
• Bacterial culture and Gram stain
• Protein and albumin
• Lactate dehydrogenase
• Glucose and pH

Placing fluid directly into blood-culture bottles at the bedside may improve the chance of identifying bacteria. Blood cultures are also commonly obtained, preferably before antibiotics when doing so will not delay treatment.

Common Diagnostic Criteria

SBE is generally diagnosed when there is no pneumonia or contiguous infection on chest imaging and one of the following is present:

• A positive pleural fluid culture with a neutrophil count above 250 cells per cubic millimeter
• A negative pleural fluid culture with a neutrophil count above 500 cells per cubic millimeter

Culture-negative infection is possible, especially if antibiotics were given before sampling or the bacterial concentration is low. Standard protein measurements alone cannot safely exclude SBE. Infected hepatic hydrothorax may retain transudative characteristics, so fluid that looks chemically “quiet” can still contain a clinically dangerous infection.

Simple Versus Complicated SBE

Some specialists describe SBE as a spectrum. A relatively simple infection may respond to antibiotics, while complicated SBE may involve pus, loculations, pleural enhancement, a fluid pH below approximately 7.2, very low glucose, or markedly elevated lactate dehydrogenase. These findings influence drainage decisions, although universally standardized SBE guidelines remain limited.

Spontaneous Bacterial Empyema Treatment

SBE is normally treated in a hospital. Care may involve hepatology, infectious-disease, pulmonary, critical-care, interventional-radiology, and transplant specialists. This is not a “take something and see how Tuesday goes” infection.

Intravenous Antibiotics

Empiric antibiotics should be started promptly after appropriate cultures are collected. A third-generation cephalosporin, such as ceftriaxone or cefotaxime, is often used for community-acquired infection when resistant bacteria are not strongly suspected.

Broader coverage may be needed for severe sepsis, hospital-acquired infection, recent antibiotic use, prior colonization with resistant organisms, or high local resistance rates. Therapy is adjusted when culture and susceptibility results become available. The exact medication and treatment duration depend on disease severity, microbiology, kidney and liver function, response to treatment, and whether the infection is complicated.

Albumin and Supportive Care

Intravenous albumin is sometimes considered by extrapolating from evidence for spontaneous bacterial peritonitis, particularly when kidney injury or circulatory dysfunction is a concern. However, its benefit specifically for SBE has not been established as firmly. Treatment is individualized rather than copied automatically from an SBP checklist.

Supportive care may include oxygen, careful blood-pressure management, kidney monitoring, electrolyte correction, and treatment of hepatic encephalopathy. Diuretics may need temporary adjustment if infection causes low blood pressure or renal dysfunction.

When Is Drainage Necessary?

Therapeutic thoracentesis may relieve significant breathlessness and provide fluid for repeat testing. A routine indwelling chest tube is generally avoided for uncomplicated infected hepatic hydrothorax because the fluid can reaccumulate continuously, producing dangerous losses of salt, water, and protein.

Drainage may nevertheless become necessary when there is frank pus, loculated infected fluid, ongoing sepsis despite suitable antibiotics, or other features of complicated pleural infection. In those situations, the immediate need for source control may outweigh the risks. The decision should be made by an experienced multidisciplinary team, with close monitoring for kidney failure, bleeding, electrolyte abnormalities, and excessive output.

Checking the Response

Doctors monitor temperature, breathing, oxygen needs, blood pressure, mental status, urine output, kidney function, and inflammatory markers. Repeat imaging or thoracentesis may be appropriate when a patient fails to improve, deteriorates, or has suspected loculations. Persistent illness can indicate resistant bacteria, inadequate source control, or an alternative diagnosis.

Managing Hepatic Hydrothorax After the Infection

Clearing the bacteria solves the emergency but not the reason the fluid accumulated. Long-term care therefore targets cirrhosis, portal hypertension, and recurrent hepatic hydrothorax.

Management may include dietary sodium restriction, carefully monitored diuretics, treatment of the underlying liver disease, and intermittent therapeutic thoracentesis for recurring symptoms. Repeated procedures carry cumulative risks, so refractory hydrothorax should prompt specialist review.

A transjugular intrahepatic portosystemic shunt, or TIPS, can reduce portal pressure in selected patients. It is not suitable for everyone, particularly those with certain heart conditions, severe liver failure, uncontrolled infection, or difficult hepatic encephalopathy.

Liver transplantation is the definitive treatment for eligible patients with decompensated cirrhosis. An episode of SBE or recurrent hepatic hydrothorax should lead to timely transplant evaluation rather than waiting for the liver to send another strongly worded memo.

Complications and Outlook

Possible complications include sepsis, septic shock, respiratory failure, acute kidney injury, recurrent infection, electrolyte disturbances, and worsening hepatic encephalopathy. Published studies report substantial short-term mortality, often around 20% or higher, although results vary with illness severity, resistance patterns, and access to advanced liver care.

Early recognition improves the opportunity to start effective antibiotics before organ failure develops. Prognosis also depends heavily on the severity of the underlying cirrhosis. Recovery from one episode does not eliminate the risk associated with recurrent hydrothorax or progressive liver disease.

Can Spontaneous Bacterial Empyema Be Prevented?

No strategy can prevent every case. Risk reduction centers on coordinated cirrhosis care: taking prescribed medications, limiting sodium as directed, avoiding alcohol, attending laboratory and imaging appointments, and reporting new breathing problems promptly.

Patients should avoid starting or stopping diuretics, antibiotics, herbal products, or over-the-counter pain relievers without medical guidance. Nonsteroidal anti-inflammatory drugs can worsen kidney function and fluid retention in cirrhosis. Preventive antibiotics may be indicated for selected patients with a history of spontaneous bacterial peritonitis or other qualifying risks, but they are not appropriate for everyone and can encourage antibiotic resistance.

Conclusion

Spontaneous bacterial empyema is an infection of hepatic hydrothorax that occurs without pneumonia. Its warning signs include fever, shortness of breath, chest discomfort, confusion, kidney decline, and unexplained deterioration in someone with cirrhosis.

Diagnosis requires chest imaging and pleural fluid testing. Prompt antibiotics form the foundation of treatment, while drainage is reserved for carefully selected situations because chest tubes can be hazardous in hepatic hydrothorax. Once the infection is controlled, attention must turn to portal hypertension, recurrent fluid, and liver transplant eligibility.

What the SBE Care Experience Can Look Like

The following is a fictional composite based on common clinical experiences. It does not describe one identifiable patient.

A person living with cirrhosis may already know the routine: morning weights, low-sodium meals, several medications, and regular appointments. When a hepatic hydrothorax has occurred before, mild breathlessness can feel like an irritating but familiar visitor. That familiarity is one reason an infection may initially be underestimated.

Imagine that the person becomes more tired over two days. Walking from the bedroom to the kitchen suddenly requires a pause. There is no dramatic cough, but family members notice slower answers and unusual sleepiness. A thermometer shows only a modest fever. Because confusion and worsening breathing can signal infection in advanced liver disease, the family calls the clinical team and is directed to the emergency department.

At the hospital, the first hours may feel hectic. Staff check oxygen levels, draw blood cultures, review medications, and order chest imaging. The X-ray shows a sizable right-sided pleural effusion but no clear pneumonia. That absence is not an all-clear; it is an important clue pointing toward infected hepatic hydrothorax.

An ultrasound-guided thoracentesis follows. The idea of a needle near the lung naturally sounds alarming, but local anesthetic is used, and imaging helps the clinician choose a safe path. Some fluid is removed for testing, and breathing may improve as pressure around the lung decreases. The laboratory reports an elevated neutrophil count. Antibiotics begin promptly while cultures are pending.

The next day, the clinical team watches more than the fever. They monitor blood pressure, urine output, creatinine, sodium, mental status, oxygen requirements, and whether the pleural fluid appears loculated. This broad surveillance can surprise families who expected treatment to focus only on the lung. In SBE, however, the infection, circulation, kidneys, brain, and liver are all unwilling participants in the same group project.

If imaging shows free-flowing fluid and the patient improves with antibiotics, the team may avoid a chest tube. Family members sometimes interpret “no drain” as undertreatment, so a clear explanation matters: hepatic hydrothorax can flow continuously through the diaphragm, and prolonged drainage may trigger major fluid, electrolyte, and protein losses. If the fluid is purulent or trapped in infected pockets, the balance changes and carefully managed drainage may be necessary.

Improvement often arrives gradually. Breathing becomes easier, alertness returns, and kidney tests stabilize. Culture results allow doctors to narrow the antibiotic. Before discharge, the conversation shifts from surviving the infection to preventing the next crisis. The patient may receive a sodium target, revised medications, follow-up laboratory testing, and instructions to seek help immediately for fever, confusion, reduced urination, or renewed breathlessness.

The most consequential discussion may involve TIPS or liver transplant evaluation. That conversation can feel intimidating, but it reflects the larger lesson of SBE: the infection is not an isolated chest problem. It is a warning that cirrhosis has entered a high-risk stage. A coordinated planand a household that recognizes subtle warning signscan turn a frightening hospitalization into a clearer path forward.